Revolving around "improving technical services, helping new drug research and development", the Center conducts researches of drug metabolism and pharmacokinetics as well as services to the pharmaceutical industry. It constructs a study platform for innovative drugs in preclinical ADME, clinical pharmacokinetics and drug metabolism, bioavailability and bioequivalence, and for young scientist cultivation in drug metabolism research. The team participates in research and development of more than 260 new drugs, among which 15 innovative drugs have been approved for marketing in China, and more than 160 have been approved for clinical trials.